Zosano Pharma

company

About

Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$14.99M
Industries
Biopharma,Biotechnology,Medical
Founded date
Oct 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization.

It was founded in 2006 and headquartered in Fremont, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$138.02M
Zosano Pharma has raised a total of $138.02M in funding over 2 rounds. Their latest funding was raised on Jun 6, 2015 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 6, 2015 Post-IPO Debt $14.99M 1 Hercules Capital Detail
Sep 19, 2013 Debt Financing $3.03M 1 Detail
Aug 6, 2009 Series B $30M 1 Detail
Nov 15, 2007 Series A $90M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Zosano Pharma is funded by 3 investors. Hercules Capital and Nomura International are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt
Nomura International Debt Financing
Phase4 Ventures Series B